Literature DB >> 18264983

Expression of endogenous nuclear bradykinin B2 receptors mediating signaling in immediate early gene activation.

Martin Savard1, David Barbaz, Simon Bélanger, Werner Müller-Esterl, Ghassan Bkaily, Pedro D'orléans-Juste, Jérôme Coté, Veronica Bovenzi, Fernand Gobeil.   

Abstract

Bradykinin (BK) represents a pro-inflammatory mediator that partakes in many inflammatory diseases. The mechanism of action of BK is thought to be primarily mediated by specific cell surface membrane B2 receptors (B2Rs). Some evidence has suggested, however, the existence of an intracellular/nuclear B2R population. Whether these receptors are functional and contribute to BK signaling remains to be determined. In this study, by mean of Western blotting, 3D-confocal microscopy, receptor autoradiography and radioligand binding analysis, we showed that plasma membrane and highly purified nuclei from isolated rat hepatocytes contain specific B2R that bind BK. The results depicting B2R nuclear expression in isolated nuclear organelles were reproduced in situ on hepatic sections by immunogold labeling and transmission electron microscopy. Functional tests on single nuclei, by means of confocal microscopy and the calcium-sensitive probe fluo-4AM, showed that BK induces concentration-dependent transitory mobilization of nucleoplasmic calcium; these responses were blocked by B2R antagonist HOE 140, not by the B1R antagonist R954 and, were also found in wild-type C57/Bl6 mice, but not in B2R-KO mice. In isolated nuclei, BK elicited activation/phosphorylation of Akt, acetylation of histone H3 and ensuing pro-inflammatory iNOS gene induction as determined by Western blot and RT-PCR. ChIP assay confirmed binding of acetylated-histone H3 complexes, but not B2R, to promoter region of iNOS gene suggesting that B2R-mediated gene expression is bridged with accessory downstream effectors. This study discloses a previously undescribed mechanism in BK-induced transcriptional events, via intracrine B2R-mediated signaling, occurring in rat autologous hepatic cells. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18264983     DOI: 10.1002/jcp.21398

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  26 in total

1.  Nuclear angiotensin-(1-7) receptor is functionally coupled to the formation of nitric oxide.

Authors:  Tanya M Gwathmey; Brian M Westwood; Nancy T Pirro; Lijun Tang; James C Rose; Debra I Diz; Mark C Chappell
Journal:  Am J Physiol Renal Physiol       Date:  2010-09-01

2.  Lack of both bradykinin B1 and B2 receptors enhances nephropathy, neuropathy, and bone mineral loss in Akita diabetic mice.

Authors:  Masao Kakoki; Kelli A Sullivan; Carey Backus; John M Hayes; Sang Su Oh; Kunjie Hua; Adil M H Gasim; Hirofumi Tomita; Ruriko Grant; Sarah B Nossov; Hyung-Suk Kim; J Charles Jennette; Eva L Feldman; Oliver Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-17       Impact factor: 11.205

Review 3.  Nuclear GPCRs in cardiomyocytes: an insider's view of β-adrenergic receptor signaling.

Authors:  George Vaniotis; Bruce G Allen; Terence E Hébert
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-09-02       Impact factor: 4.733

Review 4.  Location-dependent signaling of the group 1 metabotropic glutamate receptor mGlu5.

Authors:  Yuh-Jiin I Jong; Ismail Sergin; Carolyn A Purgert; Karen L O'Malley
Journal:  Mol Pharmacol       Date:  2014-10-17       Impact factor: 4.436

5.  Mast cell corticotropin-releasing factor subtype 2 suppresses mast cell degranulation and limits the severity of anaphylaxis and stress-induced intestinal permeability.

Authors:  Susan D'Costa; Saravanan Ayyadurai; Amelia J Gibson; Emily Mackey; Mrigendra Rajput; Laura J Sommerville; Neco Wilson; Yihang Li; Eric Kubat; Ananth Kumar; Hariharan Subramanian; Aditi Bhargava; Adam J Moeser
Journal:  J Allergy Clin Immunol       Date:  2018-11-12       Impact factor: 10.793

Review 6.  G protein-coupled receptor signalling in the cardiac nuclear membrane: evidence and possible roles in physiological and pathophysiological function.

Authors:  Artavazd Tadevosyan; George Vaniotis; Bruce G Allen; Terence E Hébert; Stanley Nattel
Journal:  J Physiol       Date:  2011-12-19       Impact factor: 5.182

7.  The human gonadotropin releasing hormone type I receptor is a functional intracellular GPCR expressed on the nuclear membrane.

Authors:  Michelle Re; Macarena Pampillo; Martin Savard; Céléna Dubuc; Craig A McArdle; Robert P Millar; P Michael Conn; Fernand Gobeil; Moshmi Bhattacharya; Andy V Babwah
Journal:  PLoS One       Date:  2010-07-08       Impact factor: 3.240

8.  Regulation of cardiac nitric oxide signaling by nuclear β-adrenergic and endothelin receptors.

Authors:  George Vaniotis; Irina Glazkova; Clémence Merlen; Carter Smith; Louis R Villeneuve; David Chatenet; Michel Therien; Alain Fournier; Artavazd Tadevosyan; Phan Trieu; Stanley Nattel; Terence E Hébert; Bruce G Allen
Journal:  J Mol Cell Cardiol       Date:  2013-05-17       Impact factor: 5.000

9.  Subcellular localization of coagulation factor II receptor-like 1 in neurons governs angiogenesis.

Authors:  Jean-Sébastien Joyal; Satra Nim; Tang Zhu; Nicholas Sitaras; José Carlos Rivera; Zhuo Shao; Przemyslaw Sapieha; David Hamel; Melanie Sanchez; Karine Zaniolo; Manon St-Louis; Johanne Ouellette; Martin Montoya-Zavala; Alexandra Zabeida; Emilie Picard; Pierre Hardy; Vikrant Bhosle; Daya R Varma; Fernand Gobeil; Christian Beauséjour; Christelle Boileau; William Klein; Morley Hollenberg; Alfredo Ribeiro-da-Silva; Gregor Andelfinger; Sylvain Chemtob
Journal:  Nat Med       Date:  2014-09-14       Impact factor: 53.440

10.  Intracrine endothelin signaling evokes IP3-dependent increases in nucleoplasmic Ca²⁺ in adult cardiac myocytes.

Authors:  Clémence Merlen; Nada Farhat; Xiaoyan Luo; David Chatenet; Artavazd Tadevosyan; Louis R Villeneuve; Marc-Antoine Gillis; Stanley Nattel; Eric Thorin; Alain Fournier; Bruce G Allen
Journal:  J Mol Cell Cardiol       Date:  2013-06-10       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.